Status:
COMPLETED
Evaluation of the Ambu® AuraGain in Ambulatory Surgery
Lead Sponsor:
Hospital General Universitario Gregorio Marañon
Conditions:
Airway
Eligibility:
All Genders
18+ years
Brief Summary
The study was designed to evaluate the success rate, time of insertion, sealing efficacy and security of the Ambu® AuraGain in patients undergoing ambulatory surgery by one anesthetist
Detailed Description
Supraglottic devices (SGD), in all their different forms, have become an authentic innovation in airway management especially in day surgery. The Ambu® AuraGainTM (Ambu A/S, Ballerup, Denmark) is a ne...
Eligibility Criteria
Inclusion
- Patients undergoing surgery procedures in ambulatory surgery usually performed with supraglottic devices.
- ASA physical status I-III patients
- Age 18-no limit
Exclusion
- Patients with known difficult airway
- Patients with increased risk of aspiration
- Patient refusal to participate in the study
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04501068
Start Date
January 1 2018
End Date
June 1 2020
Last Update
August 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Gregorio Marañon
Madrid, Spain, 28007
2
Hospital Universitario Gregorio Maranon
Madrid, Spain